Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

IPO/Stock Watch

Market trends, bell-weather stocks, filings and IPOs...

Abbisko Raises $226 Million in Hong Kong IPO for Cancer Therapies

MicroTech to Raise up to $254 Million in Hong Kong IPO for Diabetes Products

LianBio Files for $100 Million IPO on NASDAQ

Broncus Completes $200 Million Hong Kong IPO for Pulmonary Devices

Cue Health Plans $180 Million US IPO for Home Healthcare Platform

ChinaBio Event
Shanghai and Digital
May 10-14, 2021
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China